Digital entrepreneurship from cellular data: How omics afford the emergence of a new wave of digital ventures in health.

IF 7.1 3区管理学 Q1 BUSINESS

Electronic Markets Pub Date : 2023-01-01 Epub Date: 2023-09-16 DOI:10.1007/s12525-023-00669-w

Hannes Rothe, Katharina Barbara Lauer, Callum Talbot-Cooper, Daniel Juan Sivizaca Conde

{"title":"Digital entrepreneurship from cellular data: How omics afford the emergence of a new wave of digital ventures in health.","authors":"Hannes Rothe, Katharina Barbara Lauer, Callum Talbot-Cooper, Daniel Juan Sivizaca Conde","doi":"10.1007/s12525-023-00669-w","DOIUrl":null,"url":null,"abstract":"Data has become an indispensable input, throughput, and output for the healthcare industry. In recent years, omics technologies such as genomics and proteomics have generated vast amounts of new data at the cellular level including molecular, structural, and functional levels. Cellular data holds the potential to innovate therapeutics, vaccines, diagnostics, consumer products, or even ancestry services. However, data at the cellular level is generated with rapidly evolving omics technologies. These technologies use scientific knowledge from resource-rich environments. This raises the question of how new ventures can use cellular-level data from omics technologies to create new products and scale their business. We report on a series of interviews and a focus group discussion with entrepreneurs, investors, and data providers. By conceptualizing omics technologies as external enablers, we show how characteristics of cellular-level data negatively affect the combination mechanisms that drive venture creation and growth. We illustrate how data characteristics set boundary conditions for innovation and entrepreneurship and highlight how ventures seek to mitigate their impact.Supplementary information: The online version contains supplementary material available at 10.1007/s12525-023-00669-w.","PeriodicalId":47719,"journal":{"name":"Electronic Markets","volume":"33 1","pages":"48"},"PeriodicalIF":7.1000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505108/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Electronic Markets","FirstCategoryId":"91","ListUrlMain":"https://doi.org/10.1007/s12525-023-00669-w","RegionNum":3,"RegionCategory":"管理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/9/16 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"BUSINESS","Score":null,"Total":0}

引用次数: 0

Abstract

Data has become an indispensable input, throughput, and output for the healthcare industry. In recent years, omics technologies such as genomics and proteomics have generated vast amounts of new data at the cellular level including molecular, structural, and functional levels. Cellular data holds the potential to innovate therapeutics, vaccines, diagnostics, consumer products, or even ancestry services. However, data at the cellular level is generated with rapidly evolving omics technologies. These technologies use scientific knowledge from resource-rich environments. This raises the question of how new ventures can use cellular-level data from omics technologies to create new products and scale their business. We report on a series of interviews and a focus group discussion with entrepreneurs, investors, and data providers. By conceptualizing omics technologies as external enablers, we show how characteristics of cellular-level data negatively affect the combination mechanisms that drive venture creation and growth. We illustrate how data characteristics set boundary conditions for innovation and entrepreneurship and highlight how ventures seek to mitigate their impact.

Supplementary information: The online version contains supplementary material available at 10.1007/s12525-023-00669-w.

Abstract Image

查看原文本刊更多论文

来自细胞数据的数字创业：组学如何为健康领域的新一波数字创业提供资金。

数据已成为医疗保健行业不可或缺的输入、吞吐量和输出。近年来，基因组学和蛋白质组学等组学技术在细胞水平上产生了大量新数据，包括分子、结构和功能水平。细胞数据具有创新疗法、疫苗、诊断、消费品甚至祖先服务的潜力。然而，细胞水平的数据是通过快速发展的组学技术产生的。这些技术利用了资源丰富的环境中的科学知识。这就提出了一个问题，即新企业如何利用组学技术的细胞级数据来创造新产品并扩大业务。我们报道了一系列采访和与企业家、投资者和数据提供商的焦点小组讨论。通过将组学技术概念化为外部推动者，我们展示了细胞水平数据的特征如何对推动风险创建和增长的组合机制产生负面影响。我们展示了数据特征如何为创新和创业设定边界条件，并强调了企业如何寻求减轻其影响。补充信息：在线版本包含补充材料，网址为10.1007/s12525-023-00669-w。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Electronic Markets Multiple-

CiteScore

14.80

自引率

15.30%

发文量

期刊介绍： Electronic Markets (EM) stands as a premier academic journal providing a dynamic platform for research into various forms of networked business. Recognizing the pivotal role of information and communication technology (ICT), EM delves into how ICT transforms the interactions between organizations and customers across diverse domains such as social networks, electronic commerce, supply chain management, and customer relationship management. Electronic markets, in essence, encompass the realms of networked business where multiple suppliers and customers engage in economic transactions within single or multiple tiers of economic value chains. This broad concept encompasses various forms, including allocation platforms with dynamic price discovery mechanisms, fostering atomistic relationships. Notable examples originate from financial markets (e.g., CBOT, XETRA) and energy markets (e.g., EEX, ICE). Join us in exploring the multifaceted landscape of electronic markets and their transformative impact on business interactions and dynamics.